LINC01323

Across TCGA pan-cancer cohorts, LINC01323 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01323 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC01323 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01323 expression acts as an unfavorable survival marker, although some lineages such as STAD and SARC show a favorable association.

LIHC, KIRC, and KIRP are the cancer types where LINC01323 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.575	0.787	.005	69	view →
KIRC	DFS	Tertile	II,III,IV	0.176	0.523	.003	66	view →
KIRP	OS	Tertile	All	0.223	0.705	<.001	63	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
READ	DFS	Tertile	II,III,IV	0.027	0.818	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
UCEC	DFS	Tertile	All	0.309	0.671	.021	24	view →
STAD	DFS	Tertile	III,IV	0.764	0.549	.008	18	view →
CESC	DFS	Tertile	II,III,IV	0.193	0.705	.045	18	view →
COAD	DFS	Tertile	III,IV	0.167	0.648	.037	9	view →
SKCM	DFS	Tertile	III,IV	0.387	0.613	.035	6	view →
THCA	DFS	Quartile	IV	0.288	0.906	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01323–LIHC (OS)

Open the LIHC breakdown →